Newron Pharmaceuticals SpA (XTER:NP5) Marketable Securities : €4.29 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Newron Pharmaceuticals SpA's Marketable Securities for the quarter that ended in Jun. 2024 was €4.29 Mil.

Newron Pharmaceuticals SpA's annual Marketable Securities declined from Dec. 2021 (€9.58 Mil) to Dec. 2022 (€9.35 Mil) and declined from Dec. 2022 (€9.35 Mil) to Dec. 2023 (€6.26 Mil).

Newron Pharmaceuticals SpA Marketable Securities Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Marketable Securities Chart

Newron Pharmaceuticals SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

17.11

18.04

9.58

9.35

6.26

Newron Pharmaceuticals SpA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Marketable Securities	Get a 7-Day Free Trial															9.48	9.35	9.43	6.26	4.29

Newron Pharmaceuticals SpA Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Newron Pharmaceuticals SpA (XTER:NP5) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Newron Pharmaceuticals SpA Marketable Securities Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

NWPHF:USA 0QOI:UK NWRN:Switzerland

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Executives

Stefan Weber	Board of Directors
Dr. Ulrich Köstlin	Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines